Teladoc Earnings Release 2Q 2020
ir.teladochealth.com
ir.teladochealth.com
GAAP Gross margin which includes depreciation and amortization was 61.7 percent for the second quarter 2020 and 67.2% for the second quarter 2019.
EBITDA was a positive $2.7 million for the second quarter 2020 compared to a loss of $(12.2) million for the second quarter 2019.
For the full-year 2021, the company anticipates year-over-year revenue growth to be in the range of 30% to 40%.